232 filings
Page 3 of 12
CORRESP
3lnij91 0ijoa30lp9
10 Nov 21
Correspondence with SEC
12:00am
UPLOAD
061zl ca3
9 Nov 21
Letter from SEC
12:00am
8-K
fqx4khhmyleb
5 Nov 21
Sierra Oncology Reports Third Quarter 2021 Results
7:48am
424B5
sda 8zfq5o
5 Nov 21
Prospectus supplement for primary offering
7:44am
8-K
pnironj
10 Sep 21
Entry into a Material Definitive Agreement
9:51pm
8-K
4f1855ge f9
5 Aug 21
Sierra Oncology Reports Second Quarter 2021 Results
4:10pm
8-K
7ffn8 9d6e
5 Aug 21
Sierra Oncology Signs Exclusive Global In-Licensing Agreement with AstraZeneca for Novel BET Inhibitor to Expand Myelofibrosis Pipeline
4:06pm
8-K
t9s9p rk09
9 Jun 21
Submission of Matters to a Vote of Security Holders
5:01pm
DEFA14A
xy3g8aa84ic328may
3 Jun 21
Additional proxy soliciting materials
7:28am
8-K
2td8li80 xg1
3 Jun 21
Sierra Oncology Welcomes Two New Independent Directors to its Board
7:25am
8-K
u4g72asdoo1 7w
7 May 21
Sierra Oncology Reports First Quarter 2021 Results
7:54am
424B5
g1sh1grgzulmiv9hdp
7 May 21
Prospectus supplement for primary offering
7:46am
DEFA14A
ys9q0mf63vb
23 Apr 21
Additional proxy soliciting materials
7:05am
S-8
7ggxu2z
11 Mar 21
Registration of securities for employees
7:58am